VCAM-1 is significantly elevated in the ischemic hemisphere at 6 h post-stroke and plays an important role in inflammation and progression of ischemic injury after acute stroke3,7; however, it has been shown that anti-VCAM-1 antibodies did not protect against ischemic damage in animal models of stroke8. Here, VCAM1 is linked to stroke disorder.